Back
American Airlines Group Vs. Spyre Therapeutics Industry Stock Comparison
Sell
32
AAL
American Airlines Group
Last Price:
11.20
Seasonality Move:
-4.72%
Sell
27
SYRE
Spyre Therapeutics
Last Price:
22.84
Seasonality Move:
49.76%
Sell
32
American Airlines Group (AAL)
is a Sell
Is American Airlines Group a Buy, Sell or Hold?
- The current American Airlines Group [AAL] share price is $11.14. The Score for AAL is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- AAL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $22.90. The Score for SYRE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AAL Stock Price Chart
What is American Airlines Group's stock price today?
-
The American Airlines Group share price today is $11.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AAL is experiencing selling pressure, which indicates risk of future bearish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $22.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.
AAL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.6 | Sell |
| Relative Strength Index (14 RSI): | 28.68 | Sell |
| Chaikin Money Flow: | -20229984 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.9 - 13.12) | Sell |
| Bollinger Bands (100): | (12.55 - 15.17) | Sell |
SYRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.94 | Sell |
| Relative Strength Index (14 RSI): | 28.27 | Sell |
| Chaikin Money Flow: | -408420 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.66 - 36.8) | Sell |
| Bollinger Bands (100): | (27.1 - 39.22) | Sell |
AAL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.27 | Sell |
| 20-day SMA: | 11.5 | Sell |
| 50-day SMA: | 13.09 | Sell |
| 200-day SMA: | 13.41 | Sell |
| 8-day EMA: | 11.27 | Sell |
| 20-day EMA: | 11.76 | Sell |
| 50-day EMA: | 12.71 | Sell |
| 200-day EMA: | 13.71 | Sell |
SYRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.49 | Sell |
| 20-day SMA: | 31.58 | Sell |
| 50-day SMA: | 33.73 | Sell |
| 200-day SMA: | 24.46 | Sell |
| 8-day EMA: | 26.49 | Sell |
| 20-day EMA: | 30.15 | Sell |
| 50-day EMA: | 32.53 | Sell |
| 200-day EMA: | 27.05 | Sell |
American Airlines Group Earnings Growth & AAL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.38 per share, an increase next quarter of $0.66 per share, a decrease this year of $0.40 per share, and an increase next year of $0.74 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
American Airlines Group Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Spyre Therapeutics Technical Analysis
| Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||